QIAGEN Launches artus Prep&Amp as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing CapacityBusiness Wire • 04/20/21
QIAGEN Adds to COVID-19 Portfolio With New Ultra-Fast Sequencing Solution for High-Throughput Genomic SurveillanceBusiness Wire • 04/06/21
QIAGEN Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding COVID-19 PortfolioBusiness Wire • 03/29/21
QIAGEN Launches QIAsphere Cloud-Based Connectivity Solution to Enhance QIAstat-Dx Capabilities in Digital DiagnosticsBusiness Wire • 03/03/21
QIAGEN Launches QIAcube Connect MDx Platform for Automated Sample Processing in Diagnostic LabsBusiness Wire • 03/02/21
QIAGEN and INOVIO Expand Collaboration to Develop Next Generation Sequencing (NGS) Companion Diagnostic for INOVIO's VGX-3100 for Advanced Cervical DysplasiaBusiness Wire • 02/24/21
QIAGEN N.V. (QGEN) CEO Thierry Bernard on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/10/21
QIAGEN Beats Outlook for Fourth Quarter and Full-Year 2020, Reaffirms Expectations for Further Growth in 2021Business Wire • 02/09/21
QIAGEN Adds dPCR Platform QIAcuity to Growing Portfolio of COVID-19 Testing Solutions for Wastewater and Mutation TestingBusiness Wire • 01/28/21